Half facts and innuendo really inspire informed discussion. Lets look at some facts The directors and scientists associated with Solamind have never sold SLA shares in fact over an extended period they were significant buyers. You can bet they are not holding for a $1 a share-they already had that window and passed-overhang issue for current investors? pleeease?!? Russian science has managed to get man into space an achievement it shares with only one other country Russian culture and history has created serious health issues relating to alcohol abuse the most significant manifestation being the level of liver disease in Russia and its effect on male life expectancy. Ropren has been approved in a country which prides itself on its scientific heritage-have you looked at the serious scientific credentials of our TGA -they are nearly non existent Why would a substance which responds to a country's core health issue be given status as a prescribed medicine in an environment of high level scientific expertise-beggars the imagination Russian packaging may not be up to snuff but Russian science will hold its own with any in the world. Oh and our NZ doctor -why we she risk her credibility -obviously Ropren had a profound effect on her albeit indirectly. Remember the world was once flat and I'm sure there were a whole lot of posters wanting to short Galileo Come on down
SLA Price at posting:
44.2¢ Sentiment: LT Buy Disclosure: Held
